Endometrial Carcinoma

  • Michael T. Mazur
  • Robert J. Kurman


Endometrial adenocarcinoma is the most common malignant tumor of the female genital tract in the United States. This neoplasm represents a biologically and morphologically diverse group of tumors, with differing pathogenesis.1–3 The typical endometrial adenocarcinoma is well to moderately differentiated, with or without squamous differentiation, and accounts for 80% to 85% of all endometrial carcinomas. The typical patient is perimenopausal or postmenopausal, obese, hypertensive, and diabetic. The low-grade tumors are frequently associated with hyperplasia, especially atypical hyperplasia, conditions that result from unopposed estrogenic stimulation. Unopposed estrogenic stimulation due to anovulatory cycles normally occurs at the time of menopause or in younger women with the Stein-Leventhal syndrome.


Endometrial Carcinoma Nuclear Grade Clear Cell Carcinoma Mucinous Carcinoma Serous Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Smith M, McCartney AJ: Occult, high-risk endometrial cancer. Gynecol Oncol 1985;22:154–161.PubMedCrossRefGoogle Scholar
  2. 2.
    Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983; 15:10.PubMedCrossRefGoogle Scholar
  3. 3.
    Kurman RJ, Zaino RJ, Norris HJ: Endometrial carcinoma. In: Blaustein’s Pathology of the Female Genital Tract. 4th ed. Kurman RJ, ed. New York: Springer-Verlag, 1994;439–486.CrossRefGoogle Scholar
  4. 4.
    Alberhasky RC, Connelly PJ, Christopherson WM: Carcinoma of the endometrium. IV. Mixed adenosquamous carcinoma. Am J Clin Pathol 1982;77:655–664.PubMedGoogle Scholar
  5. 5.
    Christopherson WM, Alberhasky RC, Connelly PJ: Carcinoma of the endometrium. I. A clinico-pathologic study of clear cell carcinoma and secretory carcinoma. Cancer 1982;49:1511–1523.PubMedCrossRefGoogle Scholar
  6. 6.
    Christopherson WM, Connelly PJ, Alberhasky RC: Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease. Cancer 1983;51: 1705–1709.PubMedCrossRefGoogle Scholar
  7. 7.
    Connelly PJ, Alberhasky RC, Christopherson WM: Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma. Obstet Gynecol 1982;59:569–575.PubMedGoogle Scholar
  8. 8.
    Hendrickson M, Ross J, Eifel PJ, Cox RJ, Martinez A, et al: Adenocarcinoma of the endometrium: An analysis of 256 cases with carcinoma limited to the uterine corpus. I. Pathology review and analysis of prognostic variables. Gynecol Oncol 1982; 13: 373–392.PubMedCrossRefGoogle Scholar
  9. 9.
    Kurman RJ, Scully RE: Clear cell carcinoma of the endometrium. An analysis of 21 cases. Cancer 1976;37:872–882.PubMedCrossRefGoogle Scholar
  10. 10.
    Melhem MF, Tobon H: Mucinous adenocarcinoma of the endometrium: A clinico-pathological review of 18 cases. Int J Gynecol Pathol 1987; 6:347–355.PubMedCrossRefGoogle Scholar
  11. 11.
    Ross JC, Eifel PJ, Cox RS, Kempson RL, Hendrickson MR: Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol 1983;7:715–729.PubMedGoogle Scholar
  12. 12.
    Chen JL, Trost DC, Wilkinson EJ: Endometrial papillary adenocarcinomas: Two clinicopathological types. Int J Gynecol Pathol 1985;4:279.PubMedCrossRefGoogle Scholar
  13. 13.
    Mittal KR, Schwartz PE, Barwick KW: Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in Stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups. Cancer 1988;61:538–545.PubMedCrossRefGoogle Scholar
  14. 14.
    Wilson TO, Podratz KC, Gaffey TA, Malkasian GD, O’Brien PC, et al: Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol 1990;162: 418–426.PubMedGoogle Scholar
  15. 15.
    Zaino RJ, Kurman R, Herbold D, Gliedman J, Bundy BN, et al: The significance of squamous differentiation in endometrial carcinoma—Data from a Gynecologic Oncology Group study. Cancer 1991;68:2293–2302.PubMedCrossRefGoogle Scholar
  16. 16.
    Abeler VM, Kjorstad KE: Endometrial adenocarcinoma with squamous cell differentiation. Cancer 1992;69:488–495.PubMedCrossRefGoogle Scholar
  17. 17.
    Abeler VM, Kjorstad KE: Serous papillary carcinoma of the endometrium: A histopathological study of 22 cases. Gynecol Oncol 1990;39:266–271.PubMedCrossRefGoogle Scholar
  18. 18.
    Abeler VM, Kjorstad KE: Clear cell carcinoma of the endometrium: A histopathological and clinical study of 97 cases. Gynecol Oncol 1991; 40:207–217.PubMedCrossRefGoogle Scholar
  19. 19.
    Webb GA, Lagios MD: Clear cell carcinoma of the endometrium. Am J Obstet Gynecol 1987; 156: 1486–1491.PubMedGoogle Scholar
  20. 20.
    Dunton CJ, Balsara G, McFarland M, Hernandez E: Uterine papillary serous carcinoma. A review. Obstet Gynecol Survey 1991;46:97–102.CrossRefGoogle Scholar
  21. 21.
    Fanning J, Evans MC, Peters AJ, Samuel M, Harmon ER, et al: Endometrial adenocarcinoma histologic subtypes: Clinical and pathologic profile. Gynecol Oncol 1989;32:288–291.PubMedCrossRefGoogle Scholar
  22. 22.
    Kanbour-Shakir A, Tobon H: Primary clear cell carcinoma of the endometrium. A clinicopathologic study of 20 cases. Int J Gynecol Pathol 1991;10:67–78.PubMedCrossRefGoogle Scholar
  23. 23.
    Kadar N, Malfetano JH, Homesley HD: Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: Implications for therapy. Obstet Gynecol 1992;80:655–659.PubMedGoogle Scholar
  24. 24.
    DiSaia PJ, Creasman WT: Clinical Gynecologic Oncology. 4th ed. St. Louis: Mosby-Year Book, 1993.Google Scholar
  25. 25.
    Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ: International Histological Classification and Typing of Female Genital Tract Tumours. Berlin: Springer-Verlag, 1994.CrossRefGoogle Scholar
  26. 26.
    Creasman WT: New gynecologic cancer staging. Obstet Gynecol 1990;75:287–288.PubMedGoogle Scholar
  27. 27.
    Demopoulos RI, Dubin N, Noumoff J, et al: Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma. Obstet Gynecol 1986;68:245–250.PubMedGoogle Scholar
  28. 28.
    Christopherson WM, Alberhasky RC, Connelly PJ: Carcinoma of the endometrium: II. Papillary adenocarcinoma: A clinical pathologic study of 46 cases. AmJ Clin Pathol 1982; 77:534–540.Google Scholar
  29. 29.
    Zaino RJ, Kurman RJ, Diana KL, Morrow P: The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial carcinoma using a defined nuclear grading system: A Gynecologic Oncology Group study. Cancer 1994; In press:Google Scholar
  30. 30.
    Daniel AG, Peters WA, III: Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet Gynecol 1988; 71:612–614.PubMedGoogle Scholar
  31. 31.
    Cowles TA, MagrinaJF, Masterson BJ, Capen CV: Comparison of clinical and surgical staging in patients with endometrial carcinoma. Obstet Gynecol 1985;66:413–416.PubMedGoogle Scholar
  32. 32.
    Piver MS, Lele SB, Barlow JJ, Blumenson L: Paraaortic lymph node evaluation in stage I endometrial cancer. Obstet Gynecol 1982;59:97–100.PubMedGoogle Scholar
  33. 33.
    Nielsen AL, Thomsen HK, Nyholm HCJ: Evaluation of the reproducibility of the revised 1988 International Federation of Gynecology and Obstetrics grading system of endometrial cancers with special emphasis on nuclear grading. Cancer 1991 ; 68:2303–2309.PubMedCrossRefGoogle Scholar
  34. 34.
    Zaino RJ, Silverberg SG, Norris HJ, Bundy BN, Morrow CP, et al: The prognostic value of nuclear versus architectural grading in endometrial adenocarcinoma. A Gynecologic Oncology Group study. IntJ Gynecol Pathol 1994;13:29–36.CrossRefGoogle Scholar
  35. 35.
    Hendrickson MR, Ross JC, Kempson RL: Toward the development of morphologic criteria for well-differentiated adenocarcinoma of the endometrium. AmJ Surg Pathol 1983;7:819–838.Google Scholar
  36. 36.
    Kurman RJ, Norris HJ: Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982;49:2547–2557.PubMedCrossRefGoogle Scholar
  37. 37.
    Norris HJ, Tavassoli FA, Kurman RJ: Endometrial hyperplasia and carcinoma. Diagnostic considerations. AmJ Surg Pathol 1983;7:839–847.Google Scholar
  38. 38.
    Kraus FT: High-risk and premalignant lesions of the endometrium. Am J Surg Pathol 1985;9 (Suppl):31–40.Google Scholar
  39. 39.
    Kurman RJ, Norris HJ: Endometrial hyperplasia and related cellular changes. In: Blaustein’s Pathology of the Female Genital Tract. 4th ed. Kurman RJ, ed. New York: Springer-Verlag, 1994; 411–437.CrossRefGoogle Scholar
  40. 40.
    King A, Seraj IM, Wagner RJ: Stromal invasion in endometrial carcinoma. Am J Obstet Gynecol 1984;149:10–14.PubMedGoogle Scholar
  41. 41.
    Silverberg SG, Kurman RJ: Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of Tumor Pathology, 3rd series, Fascicle 3. Washington, DC: Armed Forces Institute of Pathology, 1992.Google Scholar
  42. 42.
    Winkler B, Alvarez S, Richart RM, Crum GP: Pitfalls in the diagnosis of endometrial neoplasia. Obstet Gynecol 1984;64:185–194.PubMedGoogle Scholar
  43. 43.
    Crum GP, Richart RM, Fenoglio CM: Adenoacanthosis of the endometrium. A clinicopathologic study in premenopausal women. Am J Surg Pathol 1981;5:15.PubMedCrossRefGoogle Scholar
  44. 44.
    Hendrickson MR, Kempson RL: Endometrial epithelial metaplasias: Proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol 1980;4:525–542.PubMedCrossRefGoogle Scholar
  45. 45.
    Blaustein A: Morular metaplasia misdiagnosed as adenoacanthoma in young women with polycystic ovarian disease. Am J Surg Pathol 1982; 6:223.PubMedCrossRefGoogle Scholar
  46. 46.
    Andersen WA, Taylor PT, Fechner RE, Pinkerton JAV: Endometrial metaplasia associated with endometrial carcinoma. Am J Obstet Gynecol 1987;157:597–604.PubMedGoogle Scholar
  47. 47.
    Clement PB: Pathology of the uterine corpus. Hum Pathol 1991;22:776–791.PubMedCrossRefGoogle Scholar
  48. 48.
    Zaman SS, Mazur MT: Endometrial papillary syncytial change. A nonspecific alteration associated with active breakdown. Am J Clin Pathol 1993; 99:741–745.PubMedGoogle Scholar
  49. 49.
    Kaku T, Tsukamoto N, Tsuruchi N, Sugihara K, Kamura T, et al: Endometrial metaplasia associated with endometrial carcinoma. Obstet Gynecol 1992;80:812–816.PubMedGoogle Scholar
  50. 50.
    Rorat E, Wallach RG: Papillary metaplasia of the endometrium: Clinical and histopathologic considerations. Obstet Gynecol 1984;64:90s–92s.PubMedCrossRefGoogle Scholar
  51. 51.
    Kurman RJ, Mazur MT: Benign diseases of the endometrium. In: Blaustein’s Pathology of the Female Genital Tract. 4th ed. Kurman RJ, ed. New York: Springer-Verlag, 1994;367–409.CrossRefGoogle Scholar
  52. 52.
    Mazur MT: Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 1981;5: 473–482.PubMedCrossRefGoogle Scholar
  53. 53.
    Young RH, Treger T, Scully RE: Atypical polypoid adenomyoma of the uterus. A report of 27 cases. AmJ Clin Pathol 1986;86:139–145.Google Scholar
  54. 54.
    Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R: Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma. AmJ Surg Pathol 1982;6:93–108.CrossRefGoogle Scholar
  55. 55.
    Clement PB, Scully ER: Endometrial hyperplasia and carcinoma. In: Tumors and Tumorlike Lesions of the Uterine Corpus and Cervix. Clement PB, Young RH, eds. New York: Churchill Livingstone, 1993; 181–264.Google Scholar
  56. 56.
    Hendrickson MR, Kempson RL: Ciliated carcinoma—A variant of endometrial adenocarcinoma. A report of 10 cases. Int J Gynecol Pathol 1983;2:1–12.PubMedCrossRefGoogle Scholar
  57. 57.
    Gould PR, Li L, Henderson DW, Barter RA, Papadimitriou JM: Cilia and ciliogenesis in endometrial adenocarcinomas. Arch Pathol Lab Med 1986;110:326–330.PubMedGoogle Scholar
  58. 58.
    Tobon H, Watkins GJ: Secretory adenocarcinoma of the endometrium. Int J Gynecol Pathol 1985; 4:328–335.PubMedCrossRefGoogle Scholar
  59. 59.
    Dawagne MP, Silverberg SG: Foam cells in endometrial carcinoma. Gynecol Oncol 1982; 13:67–75.PubMedCrossRefGoogle Scholar
  60. 60.
    Tiltman AJ: Mucinous carcinoma of the endometrium. Obstet Gynecol 1980;55:244–247.PubMedGoogle Scholar
  61. 61.
    Czernobilsky B, Katz Z, Lancet M, Gaton E: Endocervical type epithelium in endometrial carcinoma: A report of 10 cases with emphasis on histochemical methods for differential diagnosis. Am J Surg Pathol 1980;4:481–489.PubMedCrossRefGoogle Scholar
  62. 62.
    Young RH, Scully RE: Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. Am J Surg Pathol 1992;16:1092–1097.PubMedCrossRefGoogle Scholar
  63. 63.
    Cohen C, Shulman G, Budgeon LR: Endocervical and endometrial adenocarcinoma: An immuno-peroxidase and histochemical study. Am J Surg Pathol 1982;6:151–157.PubMedCrossRefGoogle Scholar
  64. 64.
    Tamimi HK, Gown AM, Kimdeobald J, Figge DC, Greer BE, et al: The utility of immunocytochem-istry in invasive adenocarcinoma of the cervix. Am J Obstet Gynecol 1992;166:1655–1662.PubMedGoogle Scholar
  65. 65.
    Maes G, Fleuren GJ, Bara J, Nap M: The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas. Int J Gynecol Pathol 1988;7:112–122.PubMedCrossRefGoogle Scholar
  66. 66.
    Dabbs DJ, Geisinger KR, Norris HT: Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 1986;10:568–576.PubMedCrossRefGoogle Scholar
  67. 67.
    Lee KR, Belinson JL: Recurrence in noninvasive endometrial carcinoma. Relationship to uterine papillary serous carcinoma. Am J Surg Pathol 1991;15:965–973.PubMedCrossRefGoogle Scholar
  68. 68.
    Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ: Uterine serous carcinoma—A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 1992;16:600–610.PubMedCrossRefGoogle Scholar
  69. 69.
    Lee KR, Belinson JL: Papillary serous adenocarcinoma of the endometrium: A clinicopathologic study of 19 cases. Gynecol Oncol 1992;46:51–54.PubMedCrossRefGoogle Scholar
  70. 70.
    Garcangiu ML, Chambers JY: Uterine papillary serous carcinoma—A study of 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 1992;47:298–305.CrossRefGoogle Scholar
  71. 71.
    Sutton GP, Brill L, Michael H, et al: Malignant papillary lesions of the endometrium. Gynecol Oncol 1987;27:294–304.PubMedCrossRefGoogle Scholar
  72. 72.
    Chambers JT, Merino M, Kohorn EL, et al: Uterine papillary serous carcinoma. Obstet Gynecol 1987;69:109.PubMedGoogle Scholar
  73. 73.
    Jeffrey JF, Krepart GV, Lotocki RJ: Papillary serous adenocarcinoma of the endometrium. Obstet Gynecol 1986;67:670.PubMedCrossRefGoogle Scholar
  74. 74.
    Silva EG, Jenkins R: Serous carcinoma in endometrial polyps. Mod Pathol 1990;3:120–128.PubMedGoogle Scholar
  75. 75.
    Simon A, Kopolovic J, Beyth Y: Primary squamous cell carcinoma of the endometrium. Gynecol Oncol 1988;31:454–461.PubMedCrossRefGoogle Scholar
  76. 76.
    Melin JR, Wanner L, Schulz DM, Cassell EE: Primary squamous cell carcinoma of the endometrium. Obstet Gynecol 1979;53:115–119.PubMedGoogle Scholar
  77. 77.
    Ryder DE: Verrucous carcinoma of the endometrium—A unique neoplasm with long survival. Obstet Gynecol 1982;59:78S–80S.PubMedGoogle Scholar
  78. 78.
    Abeler VM, Kjorstad KE, Nesland JM: Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases. Cancer 1991;68:98–105.PubMedCrossRefGoogle Scholar
  79. 79.
    Huntsman DG, Clement PB, Gilks CB, Scully RE: Small-cell carcinoma of the endometrium: A clinicopathologic study of sixteen cases. Am J Surg Pathol 1994;18:364–375.PubMedCrossRefGoogle Scholar
  80. 80.
    Olson N, Twiggs L, Sibley R: Small-cell carcinoma of the endometrium: Light microscopic and ultra-structural study of a case. Cancer 1982;50:760–765.PubMedCrossRefGoogle Scholar
  81. 81.
    Paz RA, Frigerio B, Sundblad AS, Eusebi V: Small-cell (oat cell) carcinoma of the endometrium. Arch Pathol Lab Med 1985;109:270–272.PubMedGoogle Scholar
  82. 82.
    Manivel C, Wick MR, Sibley TK: Neuroendocrine differentiation in mullerian neoplasms. An immu-nohistochemical study of a “pure” endometrial small-cell carcinoma and mixed mullerian tumor containing small-cell carcinoma. Am J Clin Pathol 1986;86:438–443.PubMedGoogle Scholar
  83. 83.
    Pesce C, Merino MJ, Chambers JT, Nogales F: Endometrial carcinoma with trophoblastic differentiation. An aggressive form of uterine cancer. Cancer 1991;68:1799–1802.PubMedCrossRefGoogle Scholar
  84. 84.
    Jones MA, Young RH, Scully RE: Endometrial adenocarcinoma with a component of giant cell carcinoma. Int J Gynecol Pathol 1991; 10:260–270.PubMedCrossRefGoogle Scholar
  85. 85.
    Arends J, Willebrand D, Gans HJD, Swaen GJV, Bosnian FT: Adenocarcinoma of the endometrium with glassy cell features—Immunohistochemical observations. Histopathology 1984;8: 873–879.PubMedCrossRefGoogle Scholar
  86. 86.
    Kumar A, Schneider V: Metastases to the uterus from extrapelvic primary tumors. Int J Gynecol Pathol 1983;2:134–140.PubMedCrossRefGoogle Scholar
  87. 87.
    Kumar NB, Hart WR: Metastases to the uterine corpus from extagenital cancers. A clinicopathologic study of 63 cases. Cancer 1982;50:2163–2169.PubMedCrossRefGoogle Scholar
  88. 88.
    Mazur MT, Hsueh S, Gersell DJ: Metastases to the female genital tract. Analysis of 325 cases. Cancer 1984;53:1978–1984.PubMedCrossRefGoogle Scholar
  89. 89.
    Ulbright TM, Roth LM: Metastatic and independent cancers of the endometrium and ovary: A clinicopathologic study of 34 cases. Hum Pathol 1985;16:28–34.PubMedCrossRefGoogle Scholar
  90. 90.
    Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, et al: Simultaneous presentation of carcinoma involving the ovary and uterine corpus. Cancer 1982;50:163–170.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Michael T. Mazur
    • 1
  • Robert J. Kurman
    • 2
    • 3
  1. 1.Crouse Irving Memorial Hospital, Health Science CenterState University of New YorkSyracuseUSA
  2. 2.Departments of Gynecology and Obstetrics and PathologyThe Johns Hopkins HospitalBaltimoreUSA
  3. 3.The Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations